Litcius/Paper detail

Sex differences in transaortic flow rate and association with all-cause mortality in patients with severe aortic stenosis

Sahrai Saeed, Anastasia Vamvakidou, Spyridon Zidros, George Papasozomenos, Vegard Lysne, Rajdeep Khattar, Roxy Senior

2021European Heart Journal - Cardiovascular Imaging18 citationsDOI

Abstract

AIMS: It is not known whether transaortic flow rate (FR) in aortic stenosis (AS) differs between men and women, and whether the commonly used cut-off of 200 mL/s is prognostic in females. We aimed to explore sex differences in the determinants of FR, and determine the best sex-specific cut-offs for prediction of all-cause mortality. METHODS AND RESULTS: Between 2010 and 2017, a total of 1564 symptomatic patients (mean age 76 ± 13 years, 51% men) with severe AS were prospectively included. Mean follow-up was 35 ± 22 months. The prevalence of cardiovascular disease was significantly higher in men than women (63% vs. 42%, P < 0.001). Men had higher left ventricular mass and lower left ventricular ejection fraction compared to women (both P < 0.001). Men were more likely to undergo an aortic valve intervention (AVI) (54% vs. 45%, P = 0.001), while the death rates were similar (42.0% in men and 40.6% in women, P = 0.580). A total of 779 (49.8%) patients underwent an AVI in which 145 (18.6%) died. In a multivariate Cox regression analysis, each 10 mL/s decrease in FR was associated with a 7% increase in hazard ratio (HR) for all-cause mortality (HR 1.07; 95% CI 1.03-1.11, P < 0.001). The best cut-off value of FR for prediction of all-cause mortality was 179 mL/s in women and 209 mL/s in men. CONCLUSION: Transaortic FR was lower in women than men. In the group undergoing AVI, lower FR was associated with increased risk of all-cause mortality, and the optimal cut-off for prediction of all-cause mortality was lower in women than men.

Topics & Concepts

MedicineInternal medicineHazard ratioCardiologyStenosisProportional hazards modelEjection fractionMortality rateAortic valve stenosisConfidence intervalHeart failureCardiac Valve Diseases and TreatmentsPulmonary Hypertension Research and TreatmentsCongenital Heart Disease Studies